期刊文献+

喜树碱衍生物抗肿瘤活性定量构效关系的DFT研究 被引量:1

The DFT Research on Quantitative Structure Activity Relationship of Camptothecin Derivative' s Antineoplasmic Activity
下载PDF
导出
摘要 采用量子化学密度泛函理论(DFT)方法,对喜树碱7位取代衍生物进行几何构型优化和电子结构计算,根据计算结果分析其抗肿瘤活性与电子结构的定量构效关系。结果表明,喜树碱7位取代衍生物抗肿瘤活性与分子总能量、8位和6位碳原子电荷密度及B环总电荷密度相关,其中影响最大的是8位碳原子电荷密度数值。 The geometry configuration and electronic structure of Camptothecin C7 position substitution derivative were optimized and computed by Quantum Chemistry density functional theory, respectively. Ac- cording to the computation, the relation between antineoplasmic activity and structure activity relationship of electronic structure were analyzed. The results show that the antineoplasmic activity of Camptothecin C7 po- sition substitution derivative is correlated on molecule total energy, C8 and C6 position atomic charge density and B ring total charge density. Especially, C8 position atomic charge density is more important in the an- tineoplasmic activity of Camptothecin C7 position substitution derivative.
作者 吴洪 高平章
出处 《数理医药学杂志》 2012年第4期421-423,共3页 Journal of Mathematical Medicine
基金 福建省泉州师范学院重点学科建设项目(No.MDSCh-2009A)资助
关键词 喜树碱 抗肿瘤活性 构效关系 密度泛函 Camptothecin antineoplasmic activity structure activity relationship density functional
  • 相关文献

参考文献4

二级参考文献54

  • 1潘显道,王存英.天然抗肿瘤药喜树碱衍生物的研究进展[J].药学学报,2003,38(9):715-720. 被引量:30
  • 2吴洪,吴清辉,柯惠堂.取代苯并咪唑的电子结构与抗病毒活性关系的研究[J].数理医药学杂志,2006,19(2):184-185. 被引量:2
  • 3[1]Wall ME, Wani MC, Cook CE, et al. Antitumor agent I. The isolation and structure of Camptothecin, a novel alkaloidal leukemia and tumor inhibitor from camptotheca acuminata [J]. J Amer Chem Soc, 1966,88(16):3888-3890.
  • 4[2]O'Leary J, Muggia FM. Camptothecins: a review of their development and schedules of administration [J]. Eur J Cancer, 1998,34(10):1500-1508.
  • 5[3]Liu LF, Desai SD, Li TK, et al. Mechanism of action of camptothecin [J]. Ann N Y Acad Sci, 2000,922:1-10.
  • 6[4]Slichenmyer WJ, Rowinsky EK, Donehower RC. The current status of camptothecin analogues as antitumor agents [J]. J Nat Cancer Inst, 85(4):271-291.
  • 7[5]Saijo N. Clinical trials of irinotecan hydrochloride in Japan [J]. Ann N Y Acad Sci, 1996,803:292-305.
  • 8[6]Broom C. Clinical studies of Topotecan [J]. Ann N Y Acad Sci, 1996,803:264-271.
  • 9[7]Mitsui I, Kumazawa E, Hirota Y, et al. A new water-soluble camptothecin derivative, DX-8 951 f, exhibits potent antitumor activity against human tumors in vitro and in vivo [J]. Jpn J Cancer Res, 1995,86:(8)776-782.
  • 10[8]Luzzio MJ, Besterman JM, Emerson DL, et al. Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I [J]. J Med Chem, 1995,38(3):395-401.

共引文献37

同被引文献5

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部